Central analgesic actions of loperamide following transient permeation of the blood brain barrier with Cereport™ (RMP-7)
- 1 August 1998
- journal article
- Published by Elsevier in Brain Research
- Vol. 801 (1-2) , 259-266
- https://doi.org/10.1016/s0006-8993(98)00571-x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A Non-invasive System for Delivering Neural Growth Factors across the Blood-Brain Barrier: A ReviewReviews in the Neurosciences, 1998
- Delivery of Loperamide Across the Blood-Brain Barrier with Polysorbate 80-Coated Polybutylcyanoacrylate NanoparticlesPharmaceutical Research, 1997
- Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional responseNature Medicine, 1996
- Controlled Modulation of BBB Permeability Using the Bradykinin Agonist, RMP-7Experimental Neurology, 1996
- Unlocking the Blood–Brain Barrier: A Role for RMP-7 in Brain Tumor TherapyExperimental Neurology, 1996
- Dissociation of blood-brain barrier permeability and the hypotensive effects of the bradykinin B2 agonist, RMP-7Immunopharmacology, 1996
- Permeability of the blood brain barrier by the bradykinin agonist, RMP-7: Evidence for a sensitive, auto-regulated, receptor-mediated systemImmunopharmacology, 1996
- Blood-Brain Barrier Penetration and in Vivo Activity of an NGF ConjugateScience, 1993
- Loperamide: Evidence of interaction with μ and δ opioid receptorsLife Sciences, 1983
- Blood‐brain barrier permeability and immobilization stressActa Physiologica Scandinavica, 1982